ExploreWatchlistsPricing
  1. JP-listed companies
  2. TSUMURA & CO.
  3. Financials
  4. Total assets

TSUMURA & CO. (4540)

Market cap
¥290.1B
P/E ratio
11.8x
Tsumura manufactures prescription and over-the-counter medicines, specializing in herbal extract powders and raw medicinal herbs across Japan, China, Laos, and the US.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal assets (Million JPY)YoY (%)
Mar 31, 2025464,380+8.44%
Mar 31, 2024428,254+7.92%
Mar 31, 2023396,813+13.06%
Mar 31, 2022350,981+10.00%
Mar 31, 2021319,063+2.58%
Mar 31, 2020311,042+8.26%
Mar 31, 2019287,322-2.17%
Mar 31, 2018293,701+32.29%
Mar 31, 2017222,008-0.21%
Mar 31, 2016222,468+3.16%
Mar 31, 2015215,654

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat